Skip to main content
. 2014 Mar 15;7(4):1695–1701.

Figure 1.

Figure 1

Patients were divided into two groups: high SKIP expressers (n=51) and low SKIP expressers (n=19). Kaplan-Meier analysis of overall survival (A) and recurrence-free survival (B) in relation to skip expression in 70 bladder cancer patients showed a highly significant separation between curves.